Total Payments
$1,696
2024 Payments
$175.81
Companies
20
Transactions
73
Medicare Patients
10,401
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$1,696 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,696 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $314.53 | 9 | $0 (2022) |
| ABBVIE INC. | $231.05 | 9 | $0 (2024) |
| Allergan, Inc. | $184.31 | 11 | $0 (2022) |
| PFIZER INC. | $170.50 | 8 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $126.89 | 7 | $0 (2021) |
| Amgen Inc. | $99.96 | 4 | $0 (2023) |
| EPI Health, LLC | $92.44 | 4 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $68.98 | 3 | $0 (2022) |
| Merz North America, Inc. | $64.32 | 2 | $0 (2018) |
| Aqua Pharmaceuticals | $62.41 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.81 | 7 | ABBVIE INC. ($153.06) |
| 2023 | $144.46 | 6 | AbbVie Inc. ($77.99) |
| 2022 | $185.56 | 10 | PFIZER INC. ($61.39) |
| 2021 | $117.63 | 5 | PFIZER INC. ($33.73) |
| 2020 | $114.88 | 4 | EPI Health, LLC ($35.48) |
| 2019 | $223.72 | 13 | Allergan Inc. ($60.72) |
| 2018 | $406.89 | 13 | Galderma Laboratories, L.P. ($147.27) |
| 2017 | $326.68 | 15 | Allergan Inc. ($81.09) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.37 | General |
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Dermatology | ||||||
| 04/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $23.01 | General |
| 09/12/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $31.15 | General |
| 08/30/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Inflammation | ||||||
| 03/23/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Inflammation | ||||||
| 03/21/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $23.83 | General |
| 11/22/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2022 | Sun Pharmaceutical Industries Inc. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Dermatology | ||||||
| 08/23/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: DERMATOLOGY | ||||||
| 04/12/2022 | Galderma Laboratories, L.P. | AKLIEF (Drug), ORACEA, TWYNEO | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: ACNE | ||||||
| 04/01/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: DERMATOLOGY | ||||||
| 03/31/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 03/22/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Inflammation | ||||||
| 03/15/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/08/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: DERMATOLOGY | ||||||
| 01/25/2022 | EPI Health, LLC | CLODERM (Drug), MINOLIRA EXTENDED RELEASE, WYNZORA | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: DERMATOLOGY | ||||||
| 12/08/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Podiatry | ||||||
| 07/13/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,181 | 5,168 | $577,975 | $288,268 |
| 2022 | 19 | 2,696 | 6,470 | $740,651 | $374,296 |
| 2021 | 18 | 2,845 | 6,166 | $677,639 | $367,488 |
| 2020 | 17 | 2,679 | 5,701 | $602,241 | $366,689 |
Total Patients
10,401
Total Services
23,505
Medicare Billing
$1.4M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 558 | 996 | $233,980 | $96,143 | 41.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 349 | 603 | $55,479 | $28,421 | 51.2% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 39 | 49 | $41,650 | $27,381 | 65.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 222 | 293 | $37,748 | $24,286 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 280 | $43,560 | $20,735 | 47.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 96 | 96 | $23,040 | $15,628 | 67.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 22 | 28 | $22,400 | $14,967 | 66.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 233 | 434 | $22,537 | $12,823 | 56.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 285 | 2,075 | $37,350 | $11,757 | 31.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 81 | 100 | $13,000 | $9,693 | 74.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 16 | 22 | $11,770 | $7,773 | 66.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 29 | $17,400 | $6,650 | 38.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 22 | 30 | $7,110 | $4,345 | 61.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 66 | 94 | $5,721 | $4,065 | 71.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $2,272 | $1,617 | 71.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 14 | 15 | $2,190 | $1,548 | 70.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 12 | $768.00 | $437.48 | 57.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 584 | 1,027 | $241,265 | $96,499 | 40.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 334 | 511 | $65,833 | $42,347 | 64.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 56 | 65 | $55,250 | $36,870 | 66.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 208 | 487 | $75,485 | $35,441 | 47.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 362 | 637 | $58,604 | $27,989 | 47.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 349 | 773 | $40,012 | $23,282 | 58.2% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 28 | 39 | $31,200 | $20,374 | 65.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 102 | 102 | $24,480 | $15,995 | 65.3% |
About Dr. David Rish, M.D
Dr. David Rish, M.D is a Dermatology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225045438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Rish, M.D has received a total of $1,696 in payments from pharmaceutical and medical device companies, with $175.81 received in 2024. These payments were reported across 73 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,696).
As a Medicare-enrolled provider, Rish has provided services to 10,401 Medicare beneficiaries, totaling 23,505 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Dermatopathology
- Location Beverly Hills, CA
- Active Since 08/01/2006
- Last Updated 02/08/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225045438
Products in Payments
- EUCRISA (Drug) $170.50
- Otezla (Drug) $99.96
- BOTOX (Biological) $82.33
- Sitavig (Drug) $65.14
- SKYRIZI (Biological) $59.32
- ENSTILAR (Drug) $53.63
- BOTOX COSMETIC (Biological) $49.64
- BLU-U (Medical Supply) $45.30
- Veltin (Drug) $44.27
- ORACEA (Drug) $42.34
- XEOMIN (Biological) $42.12
- RHOFADE (Drug) $39.92
- JUBLIA (Drug) $38.13
- Sernivo Spray (Drug) $27.84
- CLODERM (Drug) $27.30
- LIBTAYO (Biological) $26.04
- ABSORICA (Drug) $23.68
- SOOLANTRA (Drug) $23.60
- ACZONE (Drug) $23.50
- QUINJA (Drug) $23.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Beverly Hills
Dr. Paul Wallace, Md, MD
Dermatology — Payments: $668,849
Dermatology $668,849
Jacquiline Hakim, D.o, D.O
Dermatology — Payments: $103,641
Dermatology $103,641
Haleh Bakshandeh, Md, MD
Dermatology — Payments: $90,782
Dermatology $90,782
Dr. Howard Liu, M.d, M.D
Dermatology — Payments: $76,959
Dermatology $76,959
Dr. Monika Kiripolsky, M.d, M.D
Dermatology — Payments: $23,596
Dermatology $23,596
Kenneth Washenik, M.d, M.D
Dermatology — Payments: $20,007
Dermatology $20,007